The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $374,499 in first-year total cost, median $187,250.
Most frequent study sections
- Special Emphasis Panel[ZDA1 GXM-A (15)]2
Most frequent institutions
- INTUS BIOSCIENCES LLC1
- SECOND GENOME, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | High Resolution Microbiome Profiling System1R43DA043947-01 | DRISCOLL, MARK DAVID | INTUS BIOSCIENCES LLC, CT | $225,000 | ZDA1 |
| 2017 | Development of a Commercial Platform for Discovery and Validation of Key Microbial Metabolites in CNS Disorders1R44DA043954-01 | IWAI, SHOKO | SECOND GENOME, INC., CA | $149,499 | ZDA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.